Azerbaijan vs Mexico: Cause of death, by non-communicable diseases, ages 60+, male
Azerbaijan
55.5%
in 2021
Mexico
55.9%
in 2021
Azerbaijan rank
154th
Mexico rank
151st
Cause of death, by non-communicable diseases, ages 60+, male over time
- Azerbaijan
- Mexico
How they compare
Mexico currently reports 55.9% against 55.5% in Azerbaijan, a difference of 0.4%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Azerbaijan ahead.
Azerbaijan ranks 154th and Mexico ranks 151st of 185 countries.
Azerbaijan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.6% | 85.5% | 9.1% | Azerbaijan |
| 2010s | 95.2% | 88.3% | 7.0% | Azerbaijan |
| 2020s | 65.3% | 56.0% | 9.3% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Azerbaijan or Mexico?
- Mexico, at 55.9% against 55.5% in Azerbaijan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Azerbaijan and Mexico?
- 0.4%, with Mexico ahead.
- How many years of comparable data are there for Azerbaijan and Mexico?
- 6 years are reported by both, from 2000 to 2021.
- How do Azerbaijan and Mexico rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Azerbaijan ranks 154th and Mexico ranks 151st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.